AR066725A1 - Prediccion del pronostico para melanoma de cancer - Google Patents

Prediccion del pronostico para melanoma de cancer

Info

Publication number
AR066725A1
AR066725A1 ARP080102210A ARP080102210A AR066725A1 AR 066725 A1 AR066725 A1 AR 066725A1 AR P080102210 A ARP080102210 A AR P080102210A AR P080102210 A ARP080102210 A AR P080102210A AR 066725 A1 AR066725 A1 AR 066725A1
Authority
AR
Argentina
Prior art keywords
melanoma
markers
cancer
prognostic
genetic
Prior art date
Application number
ARP080102210A
Other languages
English (en)
Original Assignee
Pacif Edge Biotechnology Ltd
Ludwuig Inst For Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pacif Edge Biotechnology Ltd, Ludwuig Inst For Cancer Res filed Critical Pacif Edge Biotechnology Ltd
Publication of AR066725A1 publication Critical patent/AR066725A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Data Mining & Analysis (AREA)
  • Biomedical Technology (AREA)
  • Databases & Information Systems (AREA)
  • Primary Health Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Marcadores de pronostico, ôfirmasö genéticas (signatura) de pronostico y composiciones y procedimientos para determinar la prognosis de cáncer en un paciente, particularmente para melanoma. Uso de marcadores genéticos y de proteína para la prediccion del riesgo de progresion de un cáncer, tal como melanoma, basado en marcadores y ôfirmasö genéticas que comprenden tales marcadores. Procedimientos, composiciones, kits y dispositivos basados en tales marcadores de pronostico de cáncer, específicamente marcadores de pronostico de melanoma, (MPMs).
ARP080102210A 2007-05-24 2008-05-26 Prediccion del pronostico para melanoma de cancer AR066725A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ555363A NZ555363A (en) 2007-05-24 2007-05-24 Prognosis prediction for melanoma cancer

Publications (1)

Publication Number Publication Date
AR066725A1 true AR066725A1 (es) 2009-09-09

Family

ID=40032133

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080102210A AR066725A1 (es) 2007-05-24 2008-05-26 Prediccion del pronostico para melanoma de cancer

Country Status (17)

Country Link
US (3) US8822149B2 (es)
EP (2) EP2158332B1 (es)
JP (5) JP5943315B2 (es)
CN (1) CN101743327B (es)
AR (1) AR066725A1 (es)
AU (1) AU2008253836B2 (es)
CA (1) CA2725602A1 (es)
CL (1) CL2008001517A1 (es)
DK (2) DK3176270T3 (es)
ES (2) ES2622858T3 (es)
HK (1) HK1145342A1 (es)
NZ (1) NZ555363A (es)
PT (2) PT3176270T (es)
SG (2) SG10201912289SA (es)
TW (2) TWI582236B (es)
UY (1) UY31105A1 (es)
WO (1) WO2008143533A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120135415A1 (en) * 2002-11-15 2012-05-31 Morehouse School Of Medicine Detecting cancer with anti-cxcl13 and anti-cxcr5 antibodies
CN107102142A (zh) 2007-03-27 2017-08-29 伊缪诺维亚公司 检测腺癌的蛋白标志/标记
JP5683280B2 (ja) * 2011-01-04 2015-03-11 株式会社日立製作所 診療支援システム
CN102617734B (zh) * 2011-12-28 2013-09-04 暨南大学 抗FGF-2抗体Dab-2及其应用
US9336302B1 (en) 2012-07-20 2016-05-10 Zuci Realty Llc Insight and algorithmic clustering for automated synthesis
US9355105B2 (en) * 2012-12-19 2016-05-31 International Business Machines Corporation Indexing of large scale patient set
US20140271545A1 (en) 2013-03-14 2014-09-18 Castle Biosciences, Inc. Methods for predicting risk of metastasis in cutaneous melanoma
WO2016177722A1 (en) * 2015-05-05 2016-11-10 Medizinische Universität Wien Computerized device and method for processing image data
WO2018009887A1 (en) * 2016-07-08 2018-01-11 University Of Hawaii Joint analysis of multiple high-dimensional data using sparse matrix approximations of rank-1
US11205103B2 (en) 2016-12-09 2021-12-21 The Research Foundation for the State University Semisupervised autoencoder for sentiment analysis
US10692605B2 (en) * 2018-01-08 2020-06-23 International Business Machines Corporation Library screening for cancer probability
TW202018727A (zh) 2018-11-09 2020-05-16 財團法人工業技術研究院 整體式學習預測方法與系統
CA3128973A1 (en) 2019-03-04 2020-09-10 Bhaskar Bhattacharyya Data compression and communication using machine learning
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof
CN112200391B (zh) * 2020-11-17 2023-07-04 国网陕西省电力公司经济技术研究院 基于k-近邻互信息特征简化的配电网边缘侧负荷预测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101302627B1 (ko) 2005-01-05 2013-09-10 아비에 인코포레이티드 11-베타-하이드록시스테로이드 데하이드로게나제 타입 1 효소의 억제제
AU2006203830A1 (en) * 2005-01-07 2006-07-13 The Johins Hopkins University Biomarkers for melanoma
US7615349B2 (en) * 2006-09-07 2009-11-10 H. Lee Moffitt Cancer Center And Research Institute, Inc. Melanoma gene signature
WO2008043018A1 (en) * 2006-10-04 2008-04-10 Dana-Farber Cancer Institute, Inc. Tumor immunity

Also Published As

Publication number Publication date
US20150031578A1 (en) 2015-01-29
US20100136553A1 (en) 2010-06-03
AU2008253836B2 (en) 2014-11-27
US10266902B2 (en) 2019-04-23
AU2008253836A1 (en) 2008-11-27
HK1145342A1 (en) 2011-04-15
US20170107583A1 (en) 2017-04-20
JP2010527604A (ja) 2010-08-19
EP2158332A4 (en) 2011-01-05
EP3176270B1 (en) 2020-07-08
US8822149B2 (en) 2014-09-02
CA2725602A1 (en) 2008-11-27
DK3176270T3 (da) 2020-10-12
TWI609967B (zh) 2018-01-01
JP6404304B2 (ja) 2018-10-10
DK2158332T3 (en) 2017-05-01
US9534258B2 (en) 2017-01-03
TW201500553A (zh) 2015-01-01
ES2821300T3 (es) 2021-04-26
JP5943315B2 (ja) 2016-07-05
CN101743327A (zh) 2010-06-16
SG10201509568QA (en) 2015-12-30
JP2020150949A (ja) 2020-09-24
SG10201912289SA (en) 2020-02-27
JP2019004907A (ja) 2019-01-17
UY31105A1 (es) 2009-01-05
CN101743327B (zh) 2013-04-24
NZ555363A (en) 2009-11-27
ES2622858T3 (es) 2017-07-07
JP2015061528A (ja) 2015-04-02
CL2008001517A1 (es) 2009-01-09
PT2158332T (pt) 2017-04-26
EP2158332B1 (en) 2017-01-18
EP3176270A1 (en) 2017-06-07
JP2017079765A (ja) 2017-05-18
EP2158332A1 (en) 2010-03-03
TW200914623A (en) 2009-04-01
PT3176270T (pt) 2020-10-08
TWI582236B (zh) 2017-05-11
WO2008143533A1 (en) 2008-11-27

Similar Documents

Publication Publication Date Title
AR066725A1 (es) Prediccion del pronostico para melanoma de cancer
EP4219765A3 (en) Prostate cancer prognosis using biomarkers
EP2611941A4 (en) GENESIS OF CANCER DIAGNOSIS AND PROGNOSIS
WO2012006447A3 (en) Gene signatures for cancer prognosis
CO7160023A2 (es) Métodos y aparatos para predecir riesgo de cáncer de próstata y volumen de glándula prostática
MX2013005762A (es) Biomarcadores para la prediccion de la eficacia de una inmunoterapia contra el cancer.
WO2010004589A3 (en) Genetic variants predictive of cancer risk in humans
MX340453B (es) Biomarcadores para cancer de pulmon.
EA201270252A1 (ru) Консультативные системы и способы бурения с использованием целевых функций
BRPI0720371B8 (pt) métodos para diagnóstico ou monitoramento da progressão de câncer de próstata em um indivíduo e uso in vitro de pelo menos um homeodomínio contendo o fator de transcrição como um biomarcador para câncer de próstata
EP2582847A4 (en) METHOD AND MATERIALS FOR EVALUATING THE LOSS OF HETEROZYGOTY
WO2009037572A3 (en) Biomarker combinations for colorectal cancer
ATE509123T1 (de) Hochauflösende hochdurchsatz-hla-genotypisierung mittels klonaler sequenzierung
WO2012061515A3 (en) Methods of classifying human subjects with regard to cancer prognosis
GB0720113D0 (en) Diagnostic, prognostic and predictive testing for cancer
BRPI0907938A2 (pt) Painel de biomarcadores de carcinoma de pequenas células do pulmão
EP4039821A3 (en) Methods for predicting risk of interstitial pneumonia
WO2011112845A3 (en) Methods and compositions related to a multi-methylation assay to predict patient outcome
ATE525484T1 (de) Slco1b3-genotyp
WO2013062261A3 (en) Newly identified colon cancer marker and diagnostic kit using the same
WO2012021714A3 (en) Biomarker signatures for wellness testing
WO2012145607A3 (en) Specific copy number aberrations as predictors of breast cancer
CL2012002762A1 (es) Método para pronosticar el riesgo de recurrencia de cáncer de próstata en un sujeto, que comprende determinar los niveles de expresión de por lo menos dos marcadores y la probabilidad predictiva en base a un nomograma de kattan; dispositivos; y kit.
ES2337973B8 (es) Adenovirus auxiliares auto-inactivantes para la produccion de adenovirus recombinantes de alta capacidad.
WO2012061904A8 (en) Histone protein ubiquitination as a cancer biomarker

Legal Events

Date Code Title Description
FG Grant, registration